bioRxiv Science⌕ Search

Biology subjects

Wijayaratna, D.

Publications and source records attributed to Wijayaratna, D..

3 recordsLinked to original sources

Engineered blue-shifted melanopsins for subcellular optogenetics

Melanopsin (MeOp) is a G protein-coupled Receptor (GPCR) family photopigment, expressed in intrinsically photosensitive retinal ganglion cells (ipRGCs) that display remarkable functional diversity. In addition to non-image-forming visual functions, MeOp also controls signaling underlying the retina development, circadian clock, mood, and behavior. MeOp is bistable, recycles retinal, and can function under low retinaldehyde availability. It also activates multiple G protein heterotrimers. Though MeOp could be a versatile optogenetic tool, its potential, especially its utility for subcellular signaling control, is hampered by the broader spectral sensitivity spanning the entire visible range. Here, we use a recently reported in silico technology called Automatic Rhodopsin Modeling (ARM) to identify blue-shifting mutations of MeOp and, ultimately, allow for imaging biosensors with red light without activating the opsin. Accordingly, ARM was used to construct validated quantum mechanics/molecular mechanics (QM/MM) models for mouse MeOp (mMeOp) to search and optimize a set of mutants featuring a blue-shifted light absorption. We demonstrate that four mutants of such can be successfully expressed and display the required resistance to activation by red light; however, they are activated by yellow, green, and blue light. Localized subcellular optical activation of these mutants in macrophage cells showed localized PIP3 generation and cell migration. Further characterization showed that MeOp blue-shifted mutants are also bistable. Altogether, our data demonstrate the computer-aided engineering feasibility of opsins with desired spectral properties for subcellular optogenetic applications.

biochemistry↗

Spatiotemporal optical control of Gαq-PLCβ interactions

Cells experience time-varying and spatially heterogeneous chemokine signals in vivo, activating cell surface proteins, including G protein-coupled receptors (GPCRs). The Gq pathway activation by GPCRs is a major signaling axis with a broad physiological and pathological significance. Compared to other G members, GqGTP activates many crucial effectors, including PLC{beta} (Phospholipase C{beta}) and Rho GEFs (Rho guanine nucleotide exchange factors). PLC{beta} regulates many key processes, such as hematopoiesis, synaptogenesis, and cell cycle, and is therefore implicated in terminal - debilitating diseases, including cancer, epilepsy, Huntingtons Disease, and Alzheimers Disease. However, due to a lack of genetic and pharmacological tools, examining how the dynamic regulation of PLC{beta} signaling controls cellular physiology has been difficult. Since activated PLC{beta} induces several abrupt cellular changes, including cell morphology, examining how the other pathways downstream of Gq-GPCRs contribute to the overall signaling has also been difficult. Here we show the engineering, validation, and application of a highly selective and efficient optogenetic inhibitor (Opto-dHTH) to completely disrupt GqGTP-PLC{beta} interactions reversibly in user-defined cellular-subcellular regions on optical command. Using this newly gained PLC{beta} signaling control, our data indicate that the molecular competition between RhoGEFs and PLC{beta} for GqGTP determines the potency of Gq-GPCR-governed directional cell migration.

molecular biology↗

Molecular regulation of GPCR-G-protein-governed PIP3 generation and its adaptation

Phosphatidylinositol (3,4,5) trisphosphate (PIP3) is a plasma membrane-bound signaling phospholipid involved in many cellular signaling pathways that control crucial cellular processes and behaviors, including cytoskeleton remodeling, metabolism, chemotaxis, and apoptosis. Therefore, defective PIP3 signaling is implicated in various disease driving processes, including cancer metastasis, diabetes, obesity, and cardiovascular diseases. Upon activation by G protein-coupled receptors (GPCRs) or receptor tyrosine kinases (RTKs), phosphoinositide-3-kinases (PI3Ks) phosphorylate phosphatidylinositol (4,5) bisphosphate (PIP2), generating PIP3. Interestingly, though the mechanisms are unclear, PIP3 produced upon GPCR activation attenuates within minutes, indicating a tight temporal regulation. Our data show the subcellular redistributions of G proteins govern this PIP3 attenuation in the presence of sustained receptor stimulation, and thus meet the definition of signaling adaptation. Interestingly the observed adaptation of PIP3 was G{gamma} subtype-dependent. Considering distinct cell-tissue-specific G{gamma} expression profiles, our findings not only demonstrate how the GPCR-induced PIP3 response is adapted but also show how diversely this adaptation process is regulated by the dominant G{gamma}s of a cell.

cell biology↗